LA JOLLA, CA, April 30, 2024 – Enlaza Therapeutics, the first covalent biologic platform company, today announced a $100 million Series A financing. The financing will be used to further...
Art Pappas will be on a panel at the UNC Alternative Investments Conference in Chapel Hill, NC.
News | 02. 16. 2011
© 2024 Pappas Capital, LLC. ALL RIGHTS RESERVED.